SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 409 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,155 | +6.5% | 26,026 | +0.6% | 0.01% | +11.1% |
| Q2 2023 | $2,962 | -20.4% | 25,866 | -4.1% | 0.01% | -30.8% |
| Q1 2023 | $3,719 | +6.9% | 26,985 | +0.5% | 0.01% | 0.0% |
| Q4 2022 | $3,480 | -99.9% | 26,854 | +1.9% | 0.01% | +8.3% |
| Q3 2022 | $2,913,000 | +55.9% | 26,348 | +5.7% | 0.01% | +50.0% |
| Q2 2022 | $1,869,000 | -11.9% | 24,932 | -8.2% | 0.01% | 0.0% |
| Q1 2022 | $2,121,000 | -7.6% | 27,150 | +6.5% | 0.01% | -11.1% |
| Q4 2021 | $2,296,000 | +0.2% | 25,494 | +2.9% | 0.01% | 0.0% |
| Q3 2021 | $2,291,000 | +22.1% | 24,770 | +2.6% | 0.01% | 0.0% |
| Q2 2021 | $1,876,000 | +28.4% | 24,136 | +23.1% | 0.01% | +12.5% |
| Q1 2021 | $1,461,000 | -58.1% | 19,609 | -4.1% | 0.01% | -60.0% |
| Q4 2020 | $3,485,000 | +103.2% | 20,441 | +67.4% | 0.02% | +81.8% |
| Q3 2020 | $1,715,000 | -9.0% | 12,210 | +3.9% | 0.01% | -15.4% |
| Q2 2020 | $1,884,000 | +45.5% | 11,749 | -11.2% | 0.01% | +18.2% |
| Q1 2020 | $1,295,000 | -26.1% | 13,235 | -2.6% | 0.01% | -8.3% |
| Q4 2019 | $1,753,000 | – | 13,587 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,315,000 | $170,397,700 | 13.20% |
| EcoR1 Capital, LLC | 2,999,453 | $388,669,120 | 11.83% |
| Evolutionary Tree Capital Management, LLC | 63,756 | $8,261,502 | 7.93% |
| Tri Locum Partners LP | 119,695 | $15,510,000 | 6.27% |
| Avoro Capital Advisors LLC | 3,175,000 | $411,416,500 | 6.15% |
| Camber Capital Management LP | 1,250,000 | $161,975 | 5.56% |
| Finepoint Capital LP | 131,457 | $17,034 | 5.51% |
| ACUTA CAPITAL PARTNERS, LLC | 67,500 | $8,746,650 | 5.38% |
| Logos Global Management LP | 220,000 | $28,507,600 | 3.34% |
| AFG FIDUCIARY SERVICES LIMITED PARTNERSHIP | 33,454 | $3,401,657 | 3.20% |